BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12545628)

  • 1. [Prognostic value of tumor location of urothelial tumors of the bladder, after total cystectomy].
    Martin M; Bernardini S; Kleinclauss F; Della Negra E; Henry PC; Bittard H
    Prog Urol; 2002 Dec; 12(6):1221-7. PubMed ID: 12545628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy.
    Leissner J; Koeppen C; Wolf HK
    J Urol; 2003 Mar; 169(3):955-60. PubMed ID: 12576821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M; Nitzke T; Helke C; Vogler H; Hoschke B
    Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic significance of vascular invasion in patients with urothelial carcinoma treated with radical cystectomy].
    Hosomi M; Yoneda S; Madono K; Tanigawa G; Yazawa K; Yamaguchi S
    Hinyokika Kiyo; 2009 Nov; 55(11):665-9. PubMed ID: 19946182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series.
    Bartsch GC; Kuefer R; Gschwend JE; de Petriconi R; Hautmann RE; Volkmer BG
    Eur Urol; 2007 Mar; 51(3):690-7; discussion 697-8. PubMed ID: 16904815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinicopathological study of 218 patients with bladder carcinoma treated by radical cystectomy].
    Mitsuhata N; Takenaka T; Uesugi T; Mannami R; Mannami M; Shishido S; Masuda H; Nakano Y
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2239-44. PubMed ID: 9422068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort.
    Bassi P; Ferrante GD; Piazza N; Spinadin R; Carando R; Pappagallo G; Pagano F
    J Urol; 1999 May; 161(5):1494-7. PubMed ID: 10210380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of lymphatic metastasis in bladder cancer].
    Martínez-Piñeiro L; Madrid J; Julve E; García Cardoso JV; Ortega L; de la Peña J; Martínez-Piñeiro JA
    Arch Esp Urol; 1997 May; 50(4):365-71. PubMed ID: 9313045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?].
    Denzinger S; Burger M; Fritsche HM; Ganzer R; Blana A; Wieland WF; Otto W
    Aktuelle Urol; 2008 Jan; 39(1):58-61; discussion 62-3. PubMed ID: 18228189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic accuracy of an artificial neural network in patients undergoing radical cystectomy for bladder cancer: a comparison with logistic regression analysis.
    Bassi P; Sacco E; De Marco V; Aragona M; Volpe A
    BJU Int; 2007 May; 99(5):1007-12. PubMed ID: 17437435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
    Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.